Novel Cytotoxic Drugs
28th March - 29th March 2012 | USA
Category: Other
Address: Hilton Suites Chicago Magnificent Mile, 198 E. Delaware Place,, Chicago, IL, USA
Organiser: Hanson Wade
Website: CLICK HERE to open.NOVEL CYTOTOXIC DRUGS
Discovering and Developing Soluble, Stable and Potent Anti-Cancer Drugs
28 - 29 MARCH 2012
CHICAGO, IL
Novel cytotoxic agents have overcome many hurdles faced by their predecessors, shortening administration times, tackling drug resistance and even reducing adverse effects. With a narrow therapeutic window, there are many challenges in developing these drugs and combining efficacy, safety and convenience still remains a great challenge.
Imagine a meeting where these issues are top of the agenda. Where experts meet to consider new delivery technologies to optimize tumour delivery and reduce patient side effects. Where preclinical and clinical efficacy is discussed. And of course with coverage of how you get the right batch size, the right process, the right CMC strategy and partner with the right CMO.
The inaugural Novel Cytotoxic Drugs meeting is the world’s only dedicated event where you can address these issues and network with your peers in a frank and open environment.
Bringing together pharma, biotechs, and academic leaders as well as contract manufacturers and handling experts, this meeting will provide an unbeatable opportunity to learn from others’ experiences. Share best practices; learn from the leaders and come together to discuss the future of conventional and novel highly potent cytotoxics.
For more information:
Call: +44 (0) 20 3141 8749
Email: info@hansonwade.com
View: www.novel-cytotoxics.com
